¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"population diffusion coefficient"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • population equivalent
    Àα¸ÇØ´ç·®
  • population excess rate
    ¸ðÁý´ÜÃʰúÀ²
  • population genetics
    Áý´ÜÀ¯ÀüÇÐ
  • population mean
    ¸ðÁý´ÜÆò±Õ
  • population medicine
    Àα¸ÀÇÇÐ
  • population mutation
    Áý´Üµ¹¿¬º¯ÀÌ
  • population policy
    Àα¸Á¤Ã¥
  • population pyramid
    Àα¸¸ðÇü, Àα¸ÇǶó¹Ìµå
  • population study
    Àα¸Á¶»ç
  • population trend
    Àα¸Ãß¼¼
  • population variance
    ¸ðÁý´ÜºÐ»ê
  • passive diffusion
    ¼öµ¿È®»ê
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • radial diffusion
    ºÎê»ìÈ®»ê, ¹æ»çÈ®»ê
  • reference population
    ±âÁØÁý´Ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • agar diffusion method
    ¿ì¹«È®»ê¹ý
  • agar gel diffusion
    ¿ì¹«°ÖÈ®»ê
  • anisotropic diffusion
    ºñµî¹æÈ®»ê
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö
  • circulatory diffusion
    ¼øÈ¯È®»ê
  • column diffusion method
    ±âµÕÈ®»ê¹æ¹ý
  • diffusion chamber
    È®»ê½Ç
  • diffusion circle
    »ê¶õ¿ø
  • diffusion constant
    È®»ê»ó¼ö
  • diffusion
    È®»ê
  • diffusion equation
    È®»êµî½Ä
  • diffusion hypoxia
    È®»êÀú»ê¼ÒÁõ
  • diffusion potential
    È®»êÀüÀ§
  • diffusion rate
    È®»êÀ²
  • diffusion spectroscopy
    È®»êºÐ±¤¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • population density
    Àα¸¹Ðµµ(ÊÙËÑ̬).
  • population dynamics
    Áý´Üµ¿ÅÂ, Àα¸µ¿·ÂÇÐ(ÊÙËÄËç̰).
  • population equivalent
    Àα¸´ç·®(ÊÙËÀËâ).
  • population genetics
    Áý´ÜÀ¯ÀüÇÐ(ÊÙËôËøÌ°).
  • population growth
    Àα¸¼ºÀå(ËöË´ËÛËö).
  • population increase
    Àα¸Áõ°¡(ÊÙ̡˧).
  • population mean
    ¸ðÆò±Õ(ËḬ̂˻).
  • population mortality table
    ±¹¹Î»ý¸íÇ¥(Ë´ËÑË×ËḬ̂), ±¹¹Î»ç¸Á·üÇ¥(Ë´ËÑË×ËÎ Ëô̰).
  • population mutation
    Áý´Ü±ºµ¹¿¬º¯ÀÌ(¡­ÔÍæÔܨì¶).
  • population policy
    Àα¸Á¤Ã¥(ÊÙËøÌ¤).
  • population problem
    Àα¸¹®Á¦.
  • population pyramid
    Àα¸¸ðÇü(ËöË´ËÎÌ´).
  • population screening
    Áý´Ü°ËÁø(̤ËÀ˧̤).
  • population study
    Àα¸Á¶»ç
  • population trend
    Àα¸Ãß¼¼(ÊÙ̧ËÛ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • standard population
    Ç¥ÁØÀα¸(̡̰ËöË´).
  • stationary population
    Á¤ÁöÀα¸(ËøÌ¤ËöË´).
  • synchronous population
    µ¿Á¶¼¼Æ÷Áý´Ü
  • agar diffusion
    ÇÑõ(³»)È®»ê(¡­üªß¤).
  • agar diffusion method
    ÇÑõ(³»)È®»ê¹ý.
  • agar gel diffusion
    ÇÑõ°ÖÈ®»ê(ùÎô¸¡­üªß¤).
  • anisotropic diffusion
    ºñµî¹æ¼º È®»ê
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö(ù÷ê«üªß¤ßÈâ¦).
  • back diffusion
    ¿ªÈ®»ê(æ½üªß¤)
  • carrier mediated diffusion
    ´ãü(¸Å°³) È®»ê.
  • circle of diffusion
    »ê¶õ¿ø, Âø¶õ¿ø
  • circulatory diffusion
    ¼øÈ¯È®»ê(¡­üªß¤) ¡ì¿ëÇØ¹ý(éÁú°Ûö)¡í.
  • column diffusion method
    ±âµÕ È®»ê ¹æ¹ý
  • diffusion
    È®»ê
  • diffusion
    È®»ê(üªß¤), ¹Ì»ê(گߤ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • translational diffusion
    º´Áø È®»ê(ܽòäüªß¤)
  • transverse diffusion
    Ⱦ´Ü È®»ê(üôÓ¨üªß¤)
  • vapor diffusion methed
    Áõ±â(ñúѨ) È®»ê¹ý(üªß¤Ûö)
  • zonal diffusion
    ±¸¿ª(Ï¡æ´) È®»ê(üªß¤)
  • absorption coefficient
    Èí¼ö°è¼ö (ýåâ¥Íªâ¦)
  • activity coefficient
    Ȱ·®°è¼ö (üÀÕá°èâ¦)
  • adsorption coefficient
    ÈíÂø°è¼ö(ýåó·Ìõâ¦)
  • allosteric coefficient
    ¾Ë·Î½ºÅ׸® °è¼ö(Ìõâ¦)
  • Bohr coefficient
    º¸¾î °è¼ö(Ìõâ¦)
  • Bunsen absorption coefficient
    ºÐÁ¨ Èí¼ö°è¼ö(ýåâ¥Ìõâ¦)
  • Bunsen solubility coefficient
    ºÐÁ¨ ¿ëÇØµµ°è¼ö(éÁú°ÓøÌõâ¦)
  • coefficient
    °è¼ö(Ìõâ¦)
  • coefficient of coincidence
    µ¿½Ã°è¼ö(ÔÒãÁÌõâ¦)
  • coefficient of correlation
    »ó°ü°è¼ö(ßÓμÌõâ¦)
  • coefficient of variation
    ºÐ»ê°è¼ö(ÝÂߤÌõâ¦)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MPD main pancreatic duct; maximum permissible dose; mean population doubling; membrane potential differe...
PDL pancreatic duct ligation; periodontal ligament; poorly differentiated lymphocyte; population doublin...
PDT photodynamic therapy; population doubling time
Pop popliteal; population
POPLINE Population Information Online
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
pEPSP population excitatory postsynaptic potential
PS Population spike
PSA Population spike amplitude
PAF Population-attributable fractions
CPD cumulative population doubling
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • coefficient of correlation
    »ó°ü °è¼ö
    Á¦°öÇÏ¸é µÎ °³ÀÇ ¹«ÀÛÀ§ º¯¼öÄ¡ °£¿¡ »ó°ü Á¤µµ¸¦ ³ªÅ¸³»´Â Åë°è ¼ö´Ü. ´ëºÎºÐÀÇ »ó°ü °è¼ö°¡ Ç¥ÁØÈ­µÇ¾î +1
  • coefficient of displacement
    º¯À§ °è¼ö
  • coefficient of expansion
    ÆØÃ¢ °è¼ö
  • coefficient of linear thermal expansion
    ¿­ ÆØÃ¢ °è¼ö
    ¹°Ã¼ÀÇ ¿Âµµ¸¦ 1µµ »ó½Â½ÃÅ´¿¡ µû¸¥ ±æÀÌÀÇ Áõ°¡À².
  • coefficient of refraction
    ±¼Àý °è¼ö
  • coefficient of variability
    º¯ÀÌ °è¼ö, º¯µ¿ °è¼ö
    Æò±ÕÄ¡¿¡ ´ëÇÑ Ç¥ÁØ ÆíÂ÷ÀÇ ºñÀ².
  • damping coefficient
    °¨¼è Á¤¼ö
  • distribution coefficient
    ºÐÆ÷ °è¼ö, ºÐ¹è °è¼ö
  • filtration coefficient
    ¿©°ú °è¼ö
  • intraclass correlation coefficient
    °Ë»çÀÚ°£ ½Å·Úµµ¿¡ ´ëÇÑ µî±Þ ³» »ó°ü °è¼ö
  • isotonic coefficient
    µîÀå¼ö
  • linear coefficient of expansion
    ¼± ÆØÃ¢ °è¼ö
    °íüÀÇ ¿­ ÆØÃ¢¿¡ µû¸¥ ±æÀÌÀÇ º¯È­ ºñÀ². 0 ¡É¿¡¼­ ±æÀÌ lÀÎ ¹°Ã¼°¡ ¿Âµµ º¯È­ d¿¡ ´ëÇØ dl¸¸Å­ ¿­ ÆØÃ¢ÇÒ ¶§,
  • linear coefficient of thermal expansion
    ¼± ¿­ ÆØÃ¢ °è¼ö
  • mass absorption coefficient
    Áú·® Èí¼ö °è¼ö
  • molecular extinction coefficient
    ºÐÀÚ ¼Ò¸ê °è¼ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
diffusion The process of becoming diffused or widely spread, the spontaneous movement of molecules or other particles in solution, owing to their random thermal motion, to reach a uniform concentration throughout the solvent, a process requiring no addition of energy to the system.
(18 Nov 1997)
diffusion anoxia Diffusion hypoxia severe enough to result in the absence of oxygen in alveolar gas.
(05 Mar 2000)
diffusion chambers, culture Devices used in a technique by which cells or tissues are grown in vitro or, by implantation, in vivo within chambers permeable to diffusion of solutes across the chamber walls. The chambers are used for studies of drug effects, osmotic responses, cytogenic and immunologic phenomena, metabolism, etc., and include tissue cages.
(12 Dec 1998)
diffusion constant For the translational diffusion of solutes, diffusion is described by Fick's First Law, that states that the amount of a substance crossing a given area is proportional to the spatial gradient of concentration and the diffusion constant (D), that is related to molecular size and shape. A useful derived relationship is that the mean square distance moved by molecules in time t is 6Dt.
(18 Nov 1997)
diffusion hypoxia Abrupt transient decrease in alveolar oxygen tension when room air is inhaled at the conclusion of a nitrous oxide anaesthesia, because nitrous oxide diffusing out of the blood dilutes the alveolar oxygen.
(05 Mar 2000)
diffusion limitation The boundary layer hypothesis, that the proliferation of cells in culture is limited by the rate at which some essential component (almost certainly a growth factor) diffuses from the bulk medium into the layer immediately adjacent to the plasma membrane. By spreading out, a cell obtains a supra threshold level of the factor and can divide, if unable to spread (because of crowding or poor adhesion) then the cell will remain in the G0 stage of the cell cycle.
(18 Nov 1997)
diffusion method A method for the study of bacterial enzymes in which agar is mixed with the material (e.g., starch or milk) which is to serve as an indicator of the enzyme action and is inoculated and plated; if the bacteria produce enzymes digesting the admixed material, there will be a zone of clearing in the medium about each colony.
Synonym: diffusion method.
(05 Mar 2000)
diffusion of innovation The broad dissemination of new ideas, procedures, techniques, materials, and devices and the degree to which these are accepted and used.
(12 Dec 1998)
diffusion potential Potential arising from different rates of diffusion of ions at the interface of two dissimilar fluids, a junction potential.
(18 Nov 1997)
diffusion respiration Maintenance of oxygenation during apnea by intratracheal insufflation of oxygen at high flow rates.
Synonym: apneic oxygenation.
(05 Mar 2000)
diffusion shell A small vessel made of a semipermeable membrane through which peptone, but not serum albumin, can pass; used in performing the Abderhalden test.
(05 Mar 2000)
facilitated diffusion <physiology> A process by which substances are conveyed across cell membranes faster than would be possible by diffusion alone.
This is generally achieved by proteins that provide a hydrophilic environment for polar molecules throughout their passage through the plasma membrane, acting as either shuttles or pores.
See: symport, antiport, uniport.
(18 Nov 1997)
fick's law of diffusion The principle that a substance put into solution will tend to diffuse towards constant concentration throughout the solution.
(09 Oct 1997)
Fick's laws of diffusion The direction of movement of solutes by diffusion is always from a higher to a lower concentration and the diffusive flux JA of solute A across a plane at x is proportional to the concentration gradient of A at x; i.e., JA = -D(CA/x), the increase of concentration of solute A with time, CA/t, is directly proportional to the change in the concentration gradient, i.e., CA/t = D(fl2/x2).
(05 Mar 2000)
lateral diffusion Diffusion in two dimensions, usually referring to movement in the plane of the membrane, such as the motion of fluorescently labelled lipids or proteins measured by the technique of fluorescent recovery after photobleaching (FRAP).
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á